Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Bioatla, Inc. (BCAB)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 46,110,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   BioAtla is a biopharmaceutical company engaged in developing specific and selective antibody-based therapeutics for the treatment of various cancers. Co.'s lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and other tumor types. Co. also develops BA3021, a CAB ADC for NSCLC and Melanoma; and BA3071, which is a CAB anti-cytotoxic T-lymphocyte-associated antigen 4 antibody for renal cell carcinoma, NSCLC, small cell lung cancer, hepatocellular carcinoma, melanoma, bladder cancer, gastric cancer, and cervical cancer.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 81,495 83,495 252,735
Total Buy Value $0 $172,540 $177,620 $814,041
Total People Bought 0 4 4 4
Total Buy Transactions 0 4 5 15
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 207
  Page 8 of 9  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Levy Guy Director   –       •      –    2021-09-30 4 A $28.00 $7,501,200 I/I 267,900 1,115,817     -
   Steinman Lawrence Director   –       •      –    2021-09-15 4 AS $36.82 $16,569 D/D (450) 18,909     -
   Sievers Eric Chief Medical Officer   •       –      –    2021-08-26 4 S $39.59 $272,496 D/D (6,883) 93,766     -
   Smith Scott Andrew President   •       •      –    2021-08-26 4 S $39.63 $1,334,927 D/D (33,244) 354,719     -
   Levy Guy Director   –       •      –    2021-08-24 4 S $39.65 $21,677,012 I/I (546,709) 847,917     -
   Short Jay M Phd Chief Executive Officer   •       •       •   2021-08-24 4 S $41.60 $188,573 I/I (4,533) 793,547     -
   Short Jay M Phd Chief Executive Officer   •       •       •   2021-08-24 4 OE $18.00 $139,446 I/I 7,747 798,080     -
   Steinman Lawrence Director   –       •      –    2021-08-16 4 AS $40.60 $18,270 D/D (450) 19,359     -
   Steinman Lawrence Director   –       •      –    2021-07-15 4 AS $38.29 $17,231 D/D (450) 19,809     -
   Short Jay M Phd Chief Executive Officer   •       •       •   2021-07-07 4 A $0.00 $0 D/D 5,378 1,309,480     -
   Short Jay M Phd Chief Executive Officer   •       •       •   2021-06-21 4 S $38.24 $2,152,373 I/I (55,000) 790,333     -
   Short Jay M Phd Chief Executive Officer   •       •       •   2021-06-17 4 S $39.22 $755,753 I/I (19,269) 845,333     -
   Levy Guy Director   –       •      –    2021-06-17 4 S $39.16 $15,664,000 I/I (400,000) 270,553     -
   Mcbrinn Sylvia Director   –       •      –    2021-06-15 3/A IO $0.00 $0 D/D 0 425     -
   Himalaya Parent Llc 10% Owner   –       –       •   2021-06-14 4/A D $0.00 $0 D/D (8,682,254) 50     -
   Pfizer Ventures (us) Llc 10% Owner   –       –       •   2020-12-18 4 A $0.00 $0 I/I 2,238,090 2,238,090     -
   Levy Guy Director   –       •      –    2020-12-18 4 B $18.00 $25,000,020 I/I 1,388,890 333,333 2.1     -
   Levy Guy Director   –       •      –    2020-12-18 4 A $0.00 $0 I/I 1,790,472 1,790,472     -
   Cormorant Private Healthcare Fund Ii, Lp 10% Owner   –       –       •   2020-12-18 4 B $18.00 $14,400,000 I/I 800,000 2,292,060 1.5     -
   Cormorant Private Healthcare Fund Ii, Lp 10% Owner   –       –       •   2020-12-18 4 A $0.00 $0 I/I 1,492,060 1,492,060     -
   Soleus Pe Gp I, Llc 10% Owner   –       –       •   2020-12-15 3 IO $0.00 $0 D/D 0 14,871     -
   Short Jay M Phd Chief Executive OfficerOfficer   •       •       •   2020-12-15 3 IO $0.00 $0 D/D 0 569,230     -
   Short Jay M Phd Chief Executive OfficerOfficer   •       •       •   2020-12-15 3 IO $0.00 $0 I/I 0 6,358,511     -
   Himalaya Parent Llc 10% Owner   –       –       •   2020-12-15 3 IO $0.00 $0 D/D 0 6,220,050     -
   Smith Scott Andrew PresidentOfficer   •       •      –    2020-12-15 3 IO $0.00 $0 D/D 0 353,000     -

  207 Records found
  1  2  3  4  5  6  7  8  9   
  Page 8 of 9
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed